Abiopharma

Miller Steven Clive 🟡 adjusted position in 15.8K shares (4 derivative) of Warby Parker Inc. (WRBY) at $25.55 Transaction Date: Sep 03, 2025 | Filing ID: 087897

White Albert G III 🟢 acquired 10.0K shares of COOPER COMPANIES, INC. (COO) at $68.39 Transaction Date: Sep 05, 2025 | Filing ID: 006125

Graphjet Receives Nasdaq Letter

New Form DEFA14A - Silo Pharma, Inc. Filed: 2025-09-05 AccNo: 0001213900-25-085128 Size: 3 MB

New Form 144 - GoodRx Holdings, Inc. Filed: 2025-09-05 AccNo: 0001961863-25-000141 Size: 6 KB

New Form 144 - Axsome Therapeutics, Inc. Filed: 2025-09-05 AccNo: 0001921094-25-001106 Size: 4 KB

New Form ARS - Silo Pharma, Inc. Filed: 2025-09-05 AccNo: 0001213900-25-085125 Size: 796 KB

New Form S-3/A - Vivos Therapeutics, Inc. Filed: 2025-09-05 AccNo: 0001641172-25-026733 Size: 415 KB

Kooij Louise Frederika 🔴 sold 18.1K shares of NewAmsterdam Pharma Co N.V. (NAMS) at $25.09 Transaction Date: Sep 03, 2025 | Filing ID: 113276

New Form DEF 14A - Silo Pharma, Inc. Filed: 2025-09-05 AccNo: 0001213900-25-085119 Size: 4 MB

New Form 8-K - FIBROGEN INC Filed: 2025-09-05 AccNo: 0000921299-25-000007 Size: 525 KB Item 2.01: Completion of Acquisition or Disposition of Assets Item 9.01: Financial Statements and Exhibits

New Form 424B3 - Tivic Health Systems, Inc. Filed: 2025-09-05 AccNo: 0001683168-25-006729 Size: 222 KB

AGF Management Limited to Release Third Quarter 2025 Financial Results on September 24, 2025

Le 24 septembre 2025, La Société de Gestion AGF Limitée annoncera ses résultats financiers pour le troisième trimestre de 2025

AGF Reports August 2025 Assets Under Management and Fee-Earning Assets